CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 2273-2274, September 2005
© 2005 American Association for Cancer Research


Null Results in Brief

Coffee Consumption Is Not Associated with Ovarian Cancer Incidence

Susanna C. Larsson and Alicja Wolk

Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Requests for reprints: Susanna C. Larsson, Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, P.O. Box 210, SE-171 77 Stockholm, Sweden. Phone: 46-8-524-860-59; Fax: 46-8-30-45-71. E-mail: susanna.larsson{at}imm.ki.se


    Introduction
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Coffee contains many substances that could conceivably influence the risk of ovarian cancer. In a meta-analysis of the crude data of seven case-control studies of coffee consumption and ovarian cancer published before 1990, the combined odds ratio was 1.3 [95% confidence interval (95% CI), 1.1-1.5] for coffee users versus nonusers (1). Since then, at least six case-control studies have reported on the association of coffee consumption with ovarian cancer risk. Of these, two studies found a statistically significant increased risk of ovarian cancer associated with coffee consumption (2, 3), one study found a statistically significant inverse association (4), and three studies did not show any significant association (5-7).

To date, only two cohort studies, both with a small number of cases, have examined the relation between coffee consumption (assessed at baseline) and ovarian cancer risk. Although coffee consumption was not associated with mortality from ovarian cancer (n = 50 cases) in a cohort of Seventh-day Adventists (8), a Norwegian cohort reported a positive, but statistically nonsignificant, association between coffee consumption and ovarian cancer incidence (n = 93 cases; ref. 9). Given the inconclusive results on coffee consumption and ovarian cancer risk, we sought to prospectively evaluate long-term coffee consumption, using repeated measures of diet, in relation to incidence of invasive epithelial ovarian cancer among 61,057 women in the Swedish Mammography Cohort.


    Materials and Methods
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The population-based Swedish Mammography Cohort comprises 66,651 women from two counties in central Sweden who were 40 to 76 years of age on enrollment between 1987 and 1990 (10). The Swedish Mammography Cohort has been approved by the Ethics Committees at the Karolinska Institutet (Stockholm) and the Uppsala University Hospital. Dietary intake data were collected at baseline and in 1997 by self-administered food-frequency questionnaires. The Spearman correlation coefficient between coffee consumption and ovarian cancer risk, as assessed by the baseline questionnaire compared with the mean of four 1-week weighed diet records, was 0.63.

The study population for the present analysis consisted of 61,057 who were cancer-free and had at least one ovary at recruitment and who had a total energy intake within 3 SDs from the loge-transformed mean energy intake in the cohort. Complete follow-up of the cohort was accomplished through linkages with the Swedish Population, Death, Cancer, and In-Patient registers. Each participant accrued follow-up time from the date of entry into the cohort to the date of ovarian cancer diagnosis, death, bilateral oophorectomy, migration, or December 31, 2004, whichever occurred first.

To better represent long-term coffee consumption and to reduce random within-person variation, dietary information from the baseline questionnaire was used to predict ovarian cancer incidence from baseline through 1997, and the average of the baseline and 1997 intake was used to predict ovarian cancer incidence from 1998 through December 2004. Rate ratios (RR) with 95% CIs were estimated using Cox proportional hazards models stratified on age in months and the year of enrollment. Multivariate models adjusted for age, body mass index, education, parity, oral contraceptive use, and intakes of total energy, fruit, vegetables, milk, and tea. We conducted tests for linear trend by assigning the median value to each category of coffee consumption and treating this variable as a single continuous variable. All P values are two sided.


    Results
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
At baseline, 95% of the women reported drinking coffee at least once per month. The mean coffee consumption among drinkers was 2.5 cups per day. Compared with women with low coffee consumption, those with higher consumption were younger, less likely to have a post-secondary education, and consumed more milk but less tea (Table 1).


View this table:
[in this window]
[in a new window]
 
Table 1. Age-standardized baseline characteristics according to coffee consumption among participants of the Swedish Mammography Cohort

 
During 920,407 person-years of follow-up (mean, 15.1 years), 301 women were diagnosed with invasive epithelial ovarian cancer (including 135 of the serous subtype). We observed no association between baseline or long-term coffee consumption and risk of ovarian cancer after adjustment for age only or in multivariate models (Table 2). Coffee consumption was also not associated with risk of serous ovarian cancer (multivariate RR for ≥4 cups/d versus <1 cup/d, 1.11; 95% CI, 0.52-2.35).


View this table:
[in this window]
[in a new window]
 
Table 2. RRs of invasive epithelial ovarian cancer according to baseline and long-term coffee consumption in the Swedish Mammography Cohort

 

    Discussion
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this large population-based prospective cohort study, we observed no indication that long-term coffee consumption is associated with incidence of ovarian cancer. Only one previous cohort study has reported on coffee consumption and ovarian cancer incidence. In that cohort, with 93 ovarian cancer cases diagnosed among 21,238 Norwegian women followed for 10 years (9), high coffee consumption was associated with a nonsignificant increased risk of ovarian cancer. However, when examining the RRs across categories of coffee consumption, there was no monotonic dose-response relation (9); compared with the lowest category of coffee consumption (≤2 cups/d), the RRs for increasing categories (3-4, 5-6, and ≥7 cups/d) were 2.3, 2.7, and 2.0. These uncertain estimates may reflect the limited number of cases, especially in the lowest category (n = 5 cases).

Data collected in any observational study are measured with error, and nondifferential measurement error has to be considered as a possible explanation for the lack of association between coffee consumption and ovarian cancer risk in our study. Misclassification of coffee consumption may have attenuated the findings to some degree; however, this is an unlikely explanation for the absence of association over extreme categories of consumption because it is improbable that participants were misclassified from one extreme category to the other. We updated the information about diet during follow-up to provide a better measure of long-term coffee consumption and to reduce random within-person measurement error.

The strengths of our study include a population-based and prospective design, repeated measures of diet, a large size, and a large number of ovarian cancer cases. The prospective nature of the study design precluded recall and selection biases, which may have limited previous case-control studies. The practically complete cohort follow-up minimized the concern that our results have been affected by differential follow-up. Furthermore, our findings are unlikely to be explained by residual confounding because the RR estimates did not appreciably change after simultaneous controlling for potential confounding variables. Nevertheless, the possibility of confounding by unaccounted risk factors cannot be ruled out.

In summary, findings from this large population-based prospective cohort study suggest that consumption of coffee is unlikely to substantially influence the risk of ovarian cancer in middle-aged and older women.


    Footnotes
 
Grant support: Swedish Research Council/Longitudinal Studies and the Swedish Cancer Foundation.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 4/21/05; accepted 6/20/05.


    References
 Top
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. IARC. Coffee, tea, mate, methylxanthines and methylglyoxal. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon (France): IARC Press; 1991.
  2. Kuper H, Titus-Ernstoff L, Harlow BL, Cramer DW. Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 2000;88:313–8.[CrossRef][Medline]
  3. Goodman MT, Tung KH, McDuffie K, Wilkens LR, Donlon TA. Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer 2003;46:23–9.[CrossRef][Medline]
  4. Jordan SJ, Purdie DM, Green AC, Webb PM. Coffee, tea and caffeine and risk of epithelial ovarian cancer. Cancer Causes Control 2004;15:359–65.[CrossRef][Medline]
  5. Polychronopoulou A, Tzonou A, Hsieh CC, et al. Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int J Cancer 1993;55:402–7.[Medline]
  6. Tavani A, Gallus S, Dal Maso L, et al. Coffee and alcohol intake and risk of ovarian cancer: an Italian case-control study. Nutr Cancer 2001;39:29–34.[CrossRef][Medline]
  7. Riman T, Dickman PW, Nilsson S, Nordlinder H, Magnusson CM, Persson IR. Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol 2004;19:1011–9.[Medline]
  8. Snowdon DA, Phillips RL. Coffee consumption and risk of fatal cancers. Am J Public Health 1984;74:820–3.[Abstract/Free Full Text]
  9. Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 1994;5:401–8.[CrossRef][Medline]
  10. Larsson SC, Giovannucci E, Wolk A. Dietary folate intake and incidence of ovarian cancer: the Swedish Mammography Cohort. J Natl Cancer Inst 2004;96:396–402.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. J. Song, A. R. Kristal, K. G. Wicklund, K. L. Cushing-Haugen, and M. A. Rossing
Coffee, Tea, Colas, and Risk of Epithelial Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 712 - 716.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. C. Larsson and A. Wolk
Tea Consumption and Ovarian Cancer Risk in a Population-Based Cohort
Arch Intern Med, December 12, 2005; 165(22): 2683 - 2686.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, S. C.
Right arrow Articles by Wolk, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online